Tag: drugs
A Simple Solution to the Problem of ‘Product Hopping’
By Michael A. Carrier (Rutgers Law School)
Brand-name drug companies frequently switch from one version of a drug to another. Sometimes, the switch is made...
US: Celgene backs out of a $55m antitrust settlement
In an unusual move, Celgene has backed out of a $55 million settlement with patients and payers over allegations it illegally blocked competition to...
Sharing, Samples, and Generics: An Antitrust Framework
Posted by Social Science Research Network
Sharing, Samples, and Generics: An Antitrust Framework
By Michael A. Carrier (Rutgers Law School)
Abstract: Rising drug prices are in...
